P08.03 2B3-101, GLUTATHIONE PEGYLATED LIPOSOMAL DOXORUBICIN, IN PATIENTS WITH RECURRENT HIGH GRADE GLIOMAS AND BREAST CANCER BRAIN METASTASES

द्वारा Brandsma, D., Dieras, V., Altintas, S., Anders, C., Arnedos, M., Gelderblom, H., Soetekouw, P., Jager, A., van Linde, M., Aftimos, P.
प्रकाशित 2014

P04.22 Data-driven prioritization and evaluation of novel therapeutic targets in glioblastoma

द्वारा Brahm, C G, Walenkamp, A M E, van Linde, M E, Abdul, U K, Westerman, B A, Verheul, H M W, Fehrmann, R S N
में प्रकाशित Neuro Oncol (2018)

RARE-12 TOXICITY AND RESPONSE IN PATIENTS TREATED ACCORDING TO THE DUTCH SOCIETY FOR NEURO-ONCOLOGY (LWNO) MEDULLOBLASTOMA TREATMENT PROTOCOL WITH NEOADJUVANT CHEMOTHERAPY, RADIATI...

द्वारा Gravendeel, L.A., van der Rijt, C.C.D., Seute, D.T., de Vos, F.Y.F., van Linde, M.E., Eekers, D.B., Botterweck, A.A., Boogerd, W., Bromberg, J.E.C.
में प्रकाशित Neuro Oncol (2015)

P08.71 Treatment outcome of patients with recurrent glioblastoma multiforme: a retrospective multicenter analysis

द्वारा van Linde, M. E., Brahm, C. G., de Witt Hamer, P. C., Reijneveld, J. C., Bruynzeel, A. M., Wagemakers, M., van der Weide, H. L., Enting, R. H., Verheul, H. M. W., Walenkamp, A. M. E.
में प्रकाशित Neuro Oncol (2016)

Prognostic value and kinetics of circulating endothelial cells in patients with recurrent glioblastoma randomised to bevacizumab plus lomustine, bevacizumab single agent or lomusti...

द्वारा Beije, N, Kraan, J, Taal, W, van der Holt, B, Oosterkamp, H M, Walenkamp, A M, Beerepoot, L, Hanse, M, van Linde, M E, Otten, A, Vernhout, R M, de Vos, F Y F, Gratama, J W, Sleijfer, S, van den Bent, M J
में प्रकाशित Br J Cancer (2015)